(Q46806250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

molecular interaction

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Miguel A. Castanho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Salomé Veiga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yunyun Yuan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Xuqin Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gang Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

28 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

1760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

55-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290276%20AND%20SRC:MED&resulttype=core&format=json

Vesicles of variable sizes produced by a rapid extrusion procedure

9 January 2020

cites work

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

1 reference

12 December 2020

Structural characterization of the SARS-coronavirus spike S fusion protein core.

1 reference

12 December 2020

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

1 reference

12 December 2020

The identification of hydrophobic sites on the surface of proteins using absorption difference spectroscopy of bromophenol blue

1 reference

12 December 2020

Probing the mechanism of drug/lipid membrane interactions using Biacore

1 reference

12 December 2020

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

12 December 2020

Novel therapies based on mechanisms of HIV-1 cell entry.

1 reference

12 December 2020

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Mechanisms of viral membrane fusion and its inhibition

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level

1 reference

12 December 2020

The SARS-CoV S glycoprotein

1 reference

12 December 2020

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

1 reference

12 December 2020

Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Circular dichroism and Fourier transform infrared spectroscopic studies on self-assembly of tetrapeptide derivative in solution and solvated film

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

12 December 2020

A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.

1 reference

12 December 2020

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

1 reference

12 December 2020

The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface

1 reference

12 December 2020

Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide

1 reference

12 December 2020

Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

HIV fusion inhibitor peptide T-1249 is able to insert or adsorb to lipidic bilayers. Putative correlation with improved efficiency

1 reference

12 December 2020

Inhibiting HIV-1 entry with fusion inhibitors

1 reference

12 December 2020

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

12 December 2020

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020